Fingerprint
Dive into the research topics of 'Initiation and dose optimization for levodopa-carbidopa intestinal gel: Insights from phase 3 clinical trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Initiation and dose optimization for levodopa-carbidopa intestinal gel: Insights from phase 3 clinical trials
Mark F. Lew*, John T. Slevin, Rejko Krüger, Juan Carlos Martínez Castrillo, Krai Chatamra, Jordan S. Dubow, Weining Z. Robieson, Janet A. Benesh, Victor S.C. Fung
*Corresponding author for this work
Research output: Contribution to journal › Article › Research › peer-review
14
Citations
(Scopus)